Skip to main content
Erschienen in: Journal of Neurology 2/2015

01.02.2015 | Original Communication

Relationship between iron accumulation and white matter injury in multiple sclerosis: a case–control study

verfasst von: Eytan Raz, Brittany Branson, Jens H. Jensen, Maxim Bester, James S. Babb, Joseph Herbert, Robert I. Grossman, Matilde Inglese

Erschienen in: Journal of Neurology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Despite the increasing development and applications of iron imaging, the pathophysiology of iron accumulation in multiple sclerosis (MS), and its role in disease progression and development of clinical disability, is poorly understood. The aims of our study were to determine the presence and extent of iron in T2 visible lesions and gray and white matter using magnetic field correlation (MFC) MRI and correlate with microscopic white matter (WM) injury as measured by diffusion tensor imaging (DTI). This is a case–control study including a series of 31 patients with clinically definite MS. The mean age was 39 years [standard deviation (SD) = 9.55], they were 11 males and 20 females, with a disease duration average of 3 years (range 0–13) and a median EDSS of 2 (0–4.5). Seventeen healthy volunteers (6 males and 11 females) with a mean age of 36 years (SD = 11.4) were recruited. All subjects underwent MR imaging on a 3T scanner using T2-weighted sequence, 3D T1 MPRAGE, MFC, single-shot DTI and post-contrast T1. T2-lesion volumes, brain volumetry, DTI parameters and iron quantification were calculated and multiple correlations were exploited. Increased MFC was found in the putamen (p = 0.061), the thalamus (p = 0.123), the centrum semiovale (p = 0.053), globus pallidus (p = 0.008) and gray matter (GM) (p = 0.004) of MS patients compared to controls. The mean lesional MFC was 121 s−2 (SD = 67), significantly lower compared to the GM MFC (<0.0001). The GM mean diffusivity (MD) was inversely correlated with the MFC in the centrum semiovale (p < 0.001), and in the splenium of the corpus callosum (p < 0.001). Patients with MS have increased iron in the globus pallidus, putamen and centrum with a trend toward increased iron in all the brain structures. Quantitative iron evaluation of WM and GM may improve the understanding of MS pathophysiology, and might serve as a surrogate marker of disease progression.
Literatur
1.
Zurück zum Zitat Drayer B, Burger P, Hurwitz B, Dawson D, Cain J (1987) Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJR Am J Roentgenol 149(2):357–363CrossRefPubMed Drayer B, Burger P, Hurwitz B, Dawson D, Cain J (1987) Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJR Am J Roentgenol 149(2):357–363CrossRefPubMed
2.
Zurück zum Zitat Bakshi R, Dmochowski J, Shaikh ZA, Jacobs L (2001) Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci 185(1):19–26CrossRefPubMed Bakshi R, Dmochowski J, Shaikh ZA, Jacobs L (2001) Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci 185(1):19–26CrossRefPubMed
3.
Zurück zum Zitat Khalil M, Teunissen C, Langkammer C (2011) Iron and neurodegeneration in multiple sclerosis. Mult Scler Int 2011:606807PubMedCentralPubMed Khalil M, Teunissen C, Langkammer C (2011) Iron and neurodegeneration in multiple sclerosis. Mult Scler Int 2011:606807PubMedCentralPubMed
4.
Zurück zum Zitat Ge Y, Jensen JH, Lu H, Helpern JA, Miles L, Inglese M, Babb JS, Herbert J, Grossman RI (2007) Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 28(9):1639–1644CrossRefPubMed Ge Y, Jensen JH, Lu H, Helpern JA, Miles L, Inglese M, Babb JS, Herbert J, Grossman RI (2007) Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 28(9):1639–1644CrossRefPubMed
5.
Zurück zum Zitat Hammond KE, Metcalf M, Carvajal L, Okuda DT, Srinivasan R, Vigneron D, Nelson SJ, Pelletier D (2008) Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 64(6):707–713CrossRefPubMed Hammond KE, Metcalf M, Carvajal L, Okuda DT, Srinivasan R, Vigneron D, Nelson SJ, Pelletier D (2008) Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 64(6):707–713CrossRefPubMed
6.
Zurück zum Zitat Habib CA, Liu M, Bawany N, Garbern J, Krumbein I, Mentzel HJ, Reichenbach J, Magnano C, Zivadinov R, Haacke EM (2012) Assessing abnormal iron content in the deep gray matter of patients with multiple sclerosis versus healthy controls. AJNR Am J Neuroradiol 33(2):252–258CrossRefPubMed Habib CA, Liu M, Bawany N, Garbern J, Krumbein I, Mentzel HJ, Reichenbach J, Magnano C, Zivadinov R, Haacke EM (2012) Assessing abnormal iron content in the deep gray matter of patients with multiple sclerosis versus healthy controls. AJNR Am J Neuroradiol 33(2):252–258CrossRefPubMed
7.
Zurück zum Zitat Craelius W, Migdal MW, Luessenhop CP, Sugar A, Mihalakis I (1982) Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 106(8):397–399PubMed Craelius W, Migdal MW, Luessenhop CP, Sugar A, Mihalakis I (1982) Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 106(8):397–399PubMed
8.
Zurück zum Zitat Bagnato F, Hametner S, Welch EB (2013) Visualizing iron in multiple sclerosis. Magn Reson Imaging 31(3):376–384CrossRefPubMed Bagnato F, Hametner S, Welch EB (2013) Visualizing iron in multiple sclerosis. Magn Reson Imaging 31(3):376–384CrossRefPubMed
9.
Zurück zum Zitat Hametner S, Wimmer I, Haider L, Pfeifenbring S, Bruck W, Lassmann H (2013) Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol 74(6):848–861PubMedCentralCrossRefPubMed Hametner S, Wimmer I, Haider L, Pfeifenbring S, Bruck W, Lassmann H (2013) Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol 74(6):848–861PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Zivadinov R, Heininen-Brown M, Schirda CV, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Hagemeier J et al (2012) Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case–control study. Neuroimage 59(1):331–339CrossRefPubMed Zivadinov R, Heininen-Brown M, Schirda CV, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Hagemeier J et al (2012) Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case–control study. Neuroimage 59(1):331–339CrossRefPubMed
11.
Zurück zum Zitat Hagemeier J, Weinstock-Guttman B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Magnano C, Hojnacki D, Dwyer MG, Zivadinov R (2012) Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy. AJNR Am J Neuroradiol 33(8):1596–1601CrossRefPubMed Hagemeier J, Weinstock-Guttman B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Magnano C, Hojnacki D, Dwyer MG, Zivadinov R (2012) Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy. AJNR Am J Neuroradiol 33(8):1596–1601CrossRefPubMed
12.
Zurück zum Zitat Mehta V, Pei W, Yang G, Li S, Swamy E, Boster A, Schmalbrock P, Pitt D (2013) Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. PLoS One 8(3):e57573PubMedCentralCrossRefPubMed Mehta V, Pei W, Yang G, Li S, Swamy E, Boster A, Schmalbrock P, Pitt D (2013) Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. PLoS One 8(3):e57573PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Kilsdonk ID, Lopez-Soriano A, Kuijer JP, de Graaf WL, Castelijns JA, Polman CH, Luijten PR, Geurts JJ, Barkhof F, Wattjes MP (2014) Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics. J Neurol 261(7):1356–1364CrossRefPubMed Kilsdonk ID, Lopez-Soriano A, Kuijer JP, de Graaf WL, Castelijns JA, Polman CH, Luijten PR, Geurts JJ, Barkhof F, Wattjes MP (2014) Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics. J Neurol 261(7):1356–1364CrossRefPubMed
14.
Zurück zum Zitat Walsh AJ, Blevins G, Lebel RM, Seres P, Emery DJ, Wilman AH (2014) Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease. Radiology 270(1):186–196CrossRefPubMed Walsh AJ, Blevins G, Lebel RM, Seres P, Emery DJ, Wilman AH (2014) Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease. Radiology 270(1):186–196CrossRefPubMed
15.
Zurück zum Zitat Ropele S, de Graaf W, Khalil M, Wattjes MP, Langkammer C, Rocca MA, Rovira A, Palace J, Barkhof F, Filippi M et al (2011) MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging JMRI 34(1):13–21CrossRefPubMed Ropele S, de Graaf W, Khalil M, Wattjes MP, Langkammer C, Rocca MA, Rovira A, Palace J, Barkhof F, Filippi M et al (2011) MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging JMRI 34(1):13–21CrossRefPubMed
16.
Zurück zum Zitat Jensen JH, Chandra R, Ramani A, Lu H, Johnson G, Lee SP, Kaczynski K, Helpern JA (2006) Magnetic field correlation imaging. Magn Reson Med 55(6):1350–1361CrossRefPubMed Jensen JH, Chandra R, Ramani A, Lu H, Johnson G, Lee SP, Kaczynski K, Helpern JA (2006) Magnetic field correlation imaging. Magn Reson Med 55(6):1350–1361CrossRefPubMed
17.
Zurück zum Zitat Jensen JH, Szulc K, Hu C, Ramani A, Lu H, Xuan L, Falangola MF, Chandra R, Knopp EA, Schenck J et al (2009) Magnetic field correlation as a measure of iron-generated magnetic field inhomogeneities in the brain. Magn Reson Med 61(2):481–485PubMedCentralCrossRefPubMed Jensen JH, Szulc K, Hu C, Ramani A, Lu H, Xuan L, Falangola MF, Chandra R, Knopp EA, Schenck J et al (2009) Magnetic field correlation as a measure of iron-generated magnetic field inhomogeneities in the brain. Magn Reson Med 61(2):481–485PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Raz E, Jensen JH, Ge Y, Babb JS, Miles L, Reaume J, Grossman RI, Inglese M (2011) Brain iron quantification in mild traumatic brain injury: a magnetic field correlation study. AJNR Am J Neuroradiol 32(10):1851–1856CrossRefPubMed Raz E, Jensen JH, Ge Y, Babb JS, Miles L, Reaume J, Grossman RI, Inglese M (2011) Brain iron quantification in mild traumatic brain injury: a magnetic field correlation study. AJNR Am J Neuroradiol 32(10):1851–1856CrossRefPubMed
19.
Zurück zum Zitat Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O’Connor PW et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58(6):840–846CrossRefPubMed Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O’Connor PW et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58(6):840–846CrossRefPubMed
20.
Zurück zum Zitat Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of new agents in multiple sclerosis. Neurology 46(4):907–911CrossRefPubMed Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of new agents in multiple sclerosis. Neurology 46(4):907–911CrossRefPubMed
21.
Zurück zum Zitat Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, De Stefano N (2002) Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 17(1):479–489CrossRefPubMed Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, De Stefano N (2002) Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 17(1):479–489CrossRefPubMed
22.
Zurück zum Zitat Battaglini M, Jenkinson M, De Stefano N (2012) Evaluating and reducing the impact of white matter lesions on brain volume measurements. Hum Brain Mapp 33(9):2062–2071CrossRefPubMed Battaglini M, Jenkinson M, De Stefano N (2012) Evaluating and reducing the impact of white matter lesions on brain volume measurements. Hum Brain Mapp 33(9):2062–2071CrossRefPubMed
23.
Zurück zum Zitat Basser PJ, Mattiello J, LeBihan D (1994) Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B 103(3):247–254CrossRefPubMed Basser PJ, Mattiello J, LeBihan D (1994) Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B 103(3):247–254CrossRefPubMed
24.
Zurück zum Zitat Campbell A, Smith MA, Sayre LM, Bondy SC, Perry G (2001) Mechanisms by which metals promote events connected to neurodegenerative diseases. Brain Res Bull 55(2):125–132CrossRefPubMed Campbell A, Smith MA, Sayre LM, Bondy SC, Perry G (2001) Mechanisms by which metals promote events connected to neurodegenerative diseases. Brain Res Bull 55(2):125–132CrossRefPubMed
25.
Zurück zum Zitat Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor JR (2009) Oligodendrocytes and myelination: the role of iron. Glia 57(5):467–478CrossRefPubMed Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor JR (2009) Oligodendrocytes and myelination: the role of iron. Glia 57(5):467–478CrossRefPubMed
26.
Zurück zum Zitat Williams R, Buchheit CL, Berman NE, LeVine SM (2012) Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem 120(1):7–25PubMedCentralCrossRefPubMed Williams R, Buchheit CL, Berman NE, LeVine SM (2012) Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem 120(1):7–25PubMedCentralCrossRefPubMed
27.
Zurück zum Zitat Zhang X, Haaf M, Todorich B, Grosstephan E, Schieremberg H, Surguladze N, Connor JR (2005) Cytokine toxicity to oligodendrocyte precursors is mediated by iron. Glia 52(3):199–208CrossRefPubMed Zhang X, Haaf M, Todorich B, Grosstephan E, Schieremberg H, Surguladze N, Connor JR (2005) Cytokine toxicity to oligodendrocyte precursors is mediated by iron. Glia 52(3):199–208CrossRefPubMed
28.
Zurück zum Zitat Schulz K, Vulpe CD, Harris LZ, David S (2011) Iron efflux from oligodendrocytes is differentially regulated in gray and white matter. J Neurosci 31(37):13301–13311CrossRefPubMed Schulz K, Vulpe CD, Harris LZ, David S (2011) Iron efflux from oligodendrocytes is differentially regulated in gray and white matter. J Neurosci 31(37):13301–13311CrossRefPubMed
29.
Zurück zum Zitat Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55(4):458–468CrossRefPubMed Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55(4):458–468CrossRefPubMed
30.
Zurück zum Zitat Marik C, Felts PA, Bauer J, Lassmann H, Smith KJ (2007) Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain 130(Pt 11):2800–2815PubMedCentralCrossRefPubMed Marik C, Felts PA, Bauer J, Lassmann H, Smith KJ (2007) Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain 130(Pt 11):2800–2815PubMedCentralCrossRefPubMed
31.
Zurück zum Zitat Cheah JH, Kim SF, Hester LD, Clancy KW, Patterson SE 3rd, Papadopoulos V, Snyder SH (2006) NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 51(4):431–440PubMedCentralCrossRefPubMed Cheah JH, Kim SF, Hester LD, Clancy KW, Patterson SE 3rd, Papadopoulos V, Snyder SH (2006) NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 51(4):431–440PubMedCentralCrossRefPubMed
32.
Zurück zum Zitat Paling D, Tozer D, Wheeler-Kingshott C, Kapoor R, Miller DH, Golay X (2012) Reduced R2′ in multiple sclerosis normal appearing white matter and lesions may reflect decreased myelin and iron content. J Neurol Neurosurg Psychiatry 83(8):785–792CrossRefPubMed Paling D, Tozer D, Wheeler-Kingshott C, Kapoor R, Miller DH, Golay X (2012) Reduced R2′ in multiple sclerosis normal appearing white matter and lesions may reflect decreased myelin and iron content. J Neurol Neurosurg Psychiatry 83(8):785–792CrossRefPubMed
33.
Zurück zum Zitat Adisetiyo V, Jensen JH, Ramani A, Tabesh A, Di Martino A, Fieremans E, Castellanos FX, Helpern JA (2012) In vivo assessment of age-related brain iron differences by magnetic field correlation imaging. J Magn Reson Imaging JMRI 36(2):322–331CrossRefPubMed Adisetiyo V, Jensen JH, Ramani A, Tabesh A, Di Martino A, Fieremans E, Castellanos FX, Helpern JA (2012) In vivo assessment of age-related brain iron differences by magnetic field correlation imaging. J Magn Reson Imaging JMRI 36(2):322–331CrossRefPubMed
34.
Zurück zum Zitat Ramos P, Santos A, Pinto NR, Mendes R, Magalhaes T, Almeida A (2014) Iron levels in the human brain: a post-mortem study of anatomical region differences and age-related changes. J Trace Elem Med Biol 28(1):13–17CrossRefPubMed Ramos P, Santos A, Pinto NR, Mendes R, Magalhaes T, Almeida A (2014) Iron levels in the human brain: a post-mortem study of anatomical region differences and age-related changes. J Trace Elem Med Biol 28(1):13–17CrossRefPubMed
35.
Zurück zum Zitat Whitnall M, Richardson DR (2006) Iron: a new target for pharmacological intervention in neurodegenerative diseases. Semin Pediatr Neurol 13(3):186–197CrossRefPubMed Whitnall M, Richardson DR (2006) Iron: a new target for pharmacological intervention in neurodegenerative diseases. Semin Pediatr Neurol 13(3):186–197CrossRefPubMed
Metadaten
Titel
Relationship between iron accumulation and white matter injury in multiple sclerosis: a case–control study
verfasst von
Eytan Raz
Brittany Branson
Jens H. Jensen
Maxim Bester
James S. Babb
Joseph Herbert
Robert I. Grossman
Matilde Inglese
Publikationsdatum
01.02.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 2/2015
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7569-3

Weitere Artikel der Ausgabe 2/2015

Journal of Neurology 2/2015 Zur Ausgabe

Pioneers in Neurology

Heinrich Sachs (1863–1928)

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.